Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600276 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 44.30
- Day Range
- CNY 44.17–45.79
- 52-Week Range
- CNY 35.51–50.50
- Bid/Ask
- CNY 45.60 / CNY 45.61
- Market Cap
- CNY 290.95 Bil
- Volume/Avg
- 34.3 Mil / 30.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 75.02
- Price/Sales
- 12.65
- Dividend Yield (Trailing)
- 0.35%
- Dividend Yield (Forward)
- 0.35%
- Total Yield
- 0.35%
Company Profile
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 19,611
- Website
- http://www.hrs.com.cn
Comparables
Valuation
|
Metric
|
600276
|
600594
|
300194
|
|---|---|---|---|
Price/Earnings (Normalized) | 75.02 | — | 15.88 |
Price/Book Value | 7.13 | 0.99 | 1.09 |
Price/Sales | 12.65 | 1.15 | 1.73 |
Price/Cash Flow | 83.47 | 8.39 | 8.68 |
Price/Earnings
600276
600594
300194
Financial Strength
|
Metric
|
600276
|
600594
|
300194
|
|---|---|---|---|
Quick Ratio | — | 1.25 | 1.18 |
Current Ratio | — | 1.90 | 1.77 |
Interest Coverage | — | 1.12 | 10.96 |
Quick Ratio
600276
600594
300194
Profitability
|
Metric
|
600276
|
600594
|
300194
|
|---|---|---|---|
Return on Assets (Normalized) | 10.04% | −0.72% | 0.94% |
Return on Equity (Normalized) | 10.92% | −1.13% | 1.40% |
Return on Invested Capital (Normalized) | 9.87% | −0.39% | 1.12% |
Return on Assets
600276
600594
300194
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Mdrywvdqf | Fqgcs | $697.4 Bil | |
JNJ
| Johnson & Johnson | Khdpggd | Wrf | $353.8 Bil | |
MRK
| Merck & Co Inc | Fxqthlrp | Lmxs | $332.3 Bil | |
ABBV
| AbbVie Inc | Dhbljbm | Jfwb | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Vshbdmzhm | Bfwf | $232.3 Bil | |
NVS
| Novartis AG ADR | Snyqhhrr | Mwdrs | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Kjfsnqmkjc | Xrw | $195.3 Bil | |
AMGN
| Amgen Inc | Dygzqfgqw | Dzjx | $144.5 Bil | |
PFE
| Pfizer Inc | Zjwgpdkh | Ccbz | $143.8 Bil | |
SNY
| Sanofi SA ADR | Bvpbwphv | Lrhv | $122.2 Bil |